Research Article
Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
Table 2
The standardized mortality ratios of all causes of cardiovascular mortality in patients with GEP-NENs.
| CVD | Observed deaths (%) | Expected deaths | SMR (95% CI) | AER per 10,000 |
| Total | 1598 (100) | 1335.17 | 1.20 (1.14-1.26) | 12.63 | Diseases of heart | 1204 (75.3) | 1018.14 | 1.18 (1.12-1.25) | 8.93 | Hypertension without heart disease | 67 (4.2) | 47.14 | 1.42 (1.10-1.81) | 0.95 | Cerebrovascular diseases | 271 (16.9) | 223.69 | 1.21 (1.07-1.36) | 2.27 | Atherosclerosis | 9 (0.6) | 12.13 | 0.74 (0.34-1.41) | -0.15 | Aortic aneurysm and dissection | 20 (1.2) | 18.59 | 1.08 (0.66-1.66) | 0.07 | Other diseases of arteries, arterioles, capillaries | 27 (1.7) | 15.49 | 1.74 (1.15-2.54) | 0.55 |
|
|
Abbreviation: CVD: cardiovascular disease; SMR: standardized mortality ratio; CI: confidence interval; AER: absolute excess risk.
|